Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nasdaq Helsinki is the primary securities exchange in Finland and a key component of the Nasdaq Nordic market. Founded in 1912, the exchange provides a regulated marketplace for the trading of equities, bonds, and derivatives, supporting the capital needs of Finnish corporations. It plays a vital role in the Nordic life sciences ecosystem by hosting listings for numerous biotechnology, pharmaceutical, and medical technology companies. As a subsidiary of Nasdaq, Inc., it utilizes advanced trading technology to ensure market transparency and liquidity for domestic and international investors. The exchange operates several market segments, including the Main Market and First North, which cater to companies of varying sizes and growth stages.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nasdaq Helsinki.